Nintedanib esylate
| CAS No. | 656247-18-6 |
|---|---|
| MDL No. | MFCD26142360 |
| MF | C33H39N5O7S |
| MW | 649.80 |
| InChI Key | ZNMRDZZRAFJOKY-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Nintedanib esylate is an organosulfonate salt formed by combining nintedanib with one molar equivalent of ethanesulfonic acid. It is a kinase inhibitor used in the treatment of idiopathic pulmonary fibrosis and cancer. It functions as an angiogenesis inhibitor, antineoplastic agent, fibroblast growth factor receptor antagonist, tyrosine kinase inhibitor, and vascular endothelial growth factor receptor antagonist. It contains a nintedanib(1+) moiety.
| CAS No. | 656247-18-6 |
|---|---|
| Product Name | Nintedanib esylate |
Biological Targets
FGFR3·FGFR1·FGFR4·FGFR2·PDGFRB·
Associated Conditions
non-small cell lung carcinoma·Interstitial pneumonitis·systemic scleroderma·idiopathic pulmonary fibrosis
* The information provided here is compiled from public sources and is for reference only.
